Moreover, ATF5 gene polymorphisms that appear to enhance activity at the ASNS promoter are linked to asparaginase treatment resistance in childhood acute lymphoblastic leukemia [8]. This evidence concerns the gene ATF5 and acute lymphoblastic leukemia.